Corona Prandi , Bruno, Mariana P Rosim, Gabriel Ogata Pedro, and Manny Papadimitropoulos. “Cost Per Number Needed to Treat and Treatment Cost of Baricitinib Versus Adalimumab on Rheumatoid Arthritis Treatment in the Brazilian Private Healthcare System”. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA 4, no. s.1 (February 1, 2023). Accessed September 11, 2026. https://ojs.jaff.org.br/ojs/index.php/jaff/article/view/554.